Q Therapeutics, Inc. 4
4 · Q Therapeutics, Inc. · Filed Dec 22, 2014
Insider Transaction Report
Form 4
Q Therapeutics, Inc.[NONE]
Rao Mahendra S.
Chief Strategy Officer
Transactions
- Award
Option to Purchase Common Stock
2014-12-18$0.70/sh+250,000$175,000→ 1,250,000 totalExercise: $0.70From: 2015-01-31Exp: 2024-12-17→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Options to commence vesting beginning January 1, 2015, and will vest monthly in equal increments over 48 months.